Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Barclays has reported its results for the first quarter of 2025, highlighting a blend of strengths and challenges within its operations and financial metrics.</li><li>The group's performance indicates progress towards strategic goals despite a backdrop characterized by economic uncertainty and market volatility.</li><li>In Q1 2025, Barclays reported a return on tangible equity (RoTE) of 14%, demonstrating an improvement from the previous year’s 12.3%.</li></ul>

Barclays has reported its results for the first quarter of 2025, highlighting a blend of strengths and challenges within its operations and financial metrics.The group's performance indicates progress towards strategic goals despite a backdrop characterized by economic uncertainty and market volatility.In Q1 2025, Barclays reported a return on tangible equity (RoTE) of 14%, demonstrating an improvement from the previous year’s 12.3%.

Barclays PLC: Setting Its Sights on $40B U.S. Card Surge—Will This Bold Bet Pay Off?

<ul><li>Barclays' financial results for the third quarter of 2024 highlight a performance that aligns with the management's strategic objectives, yet also presents certain challenges and uncertainties.</li><li>The results showcase notable strengths in some divisions and areas that require attention.</li><li>Positives in the results are led by strong Return on Tangible Equity (RoTE) figures, which stood at 12.3% for the third quarter and 11.5% year-to-date.</li></ul>

Barclays' financial results for the third quarter of 2024 highlight a performance that aligns with the management's strategic objectives, yet also presents certain challenges and uncertainties.The results showcase notable strengths in some divisions and areas that require attention.Positives in the results are led by strong Return on Tangible Equity (RoTE) figures, which stood at 12.3% for the third quarter and 11.5% year-to-date.

Barclays’ Surprising Growth Strategy: What’s Fueling Their Global Comeback? - Major Drivers

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

US Treasury (10 Yr Generic) / Technical Analysis

<ul>
<li>We maintain our near-term bullish outlook on S&amp;P 500 (SPX) and Nasdaq 100 (QQQ), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we were neutral.</li>
<li>Our intermediate-term bullish outlook has been in place since 5/14/25. We'll stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ hold.</li>
<li>Additionally, as discussed last week (12/2/25) we believe SPX, QQQ, and Russell 2000 (IWM) are in the midst of a new lockout rally, which is likely to run through early-2026</li>
</ul>


We maintain our near-term bullish outlook on S&amp;P 500 (SPX) and Nasdaq 100 (QQQ), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we were neutral.
Our intermediate-term bullish outlook has been in place since 5/14/25. We'll stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ hold.
Additionally, as discussed last week (12/2/25) we believe SPX, QQQ, and Russell 2000 (IWM) are in the midst of a new lockout rally, which is likely to run through early-2026


Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%

<ul>
<li>We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass), with Int’l Compass reports all echoing this sentiment</li>
<li>Our bullish near-term outlook will remain in place as long as the 6-month uptrend continues on ACWI-US, which generally coincides with the 50-day MA.</li>
<li>Short-Term supports to watch on ACWI-US include the 6-month uptrend (currently at $139.40), the 50-day MA (currently $137.95), and $135.70.</li>
</ul>


We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass), with Int’l Compass reports all echoing this sentiment
Our bullish near-term outlook will remain in place as long as the 6-month uptrend continues on ACWI-US, which generally coincides with the 50-day MA.
Short-Term supports to watch on ACWI-US include the 6-month uptrend (currently at $139.40), the 50-day MA (currently $137.95), and $135.70.


Expecting Upside to Continue into Early-2026 for Global Equities $ACWI

<ul>
<li>We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass).</li>
<li>We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and SPX is above 6028-6059 (up from 5700-5785 as it is highly unlikely to be tested).</li>
<li>Some will point to August seasonality as a reason to be cautious; we simply are not seeing any signs that suggest a meaningful pullback is imminent.</li>
</ul>


We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass).
We will maintain our bullish intermediate-term outlook as long as market dynamics remain healthy and SPX is above 6028-6059 (up from 5700-5785 as it is highly unlikely to be tested).
Some will point to August seasonality as a reason to be cautious; we simply are not seeing any signs that suggest a meaningful pullback is imminent.


Market Extended Entering Seasonally Weak August; Meaningful Pullback Imminent? Not Likely

United Kingdom

Barclays PLC is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management, and investment management services.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Barclays (BCS US)

Barclays PLC: Setting Its Sights on $40B U.S. Card Surge—Will This Bold Bet Pay Off?

Barclays has reported its results for the first quarter of 2025, highlighting a blend of strengths and challenges within its operations and...

Baptista Research

Barclays’ Surprising Growth Strategy: What’s Fueling Their Global Comeback? - Major Drivers

Barclays' financial results for the third quarter of 2024 highlight a performance that aligns with the management's strategic objectives, yet also...

Baptista Research

Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%

Rising Yields a Problem?; Russell 2000 $IWM Breakout; No Concern if 10Y Treasury Yield is below 4.2%, and quite possibly 4.35%-4.50% if MOVE index...

Vermilion Research

Expecting Upside to Continue into Early-2026 for Global Equities $ACWI

Expecting Upside to Continue into Early-2026 for Global Equities $ACWI. Discussed Thursday to expect support at the 50-day MA. Actionable Themes:...

Vermilion Research

Market Extended Entering Seasonally Weak August; Meaningful Pullback Imminent? Not Likely

Market Extended Entering Seasonally Weak August; Still Little Evidence that a Meaningful Pullback is Imminent. Still Bullish $SPX $QQQ since 4/22...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)